Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Applied BioMath, LLC Announces Collaboration with Xilio Therapeutics
Tuesday, April 28, 2020Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development today announced a collaboration with Xilio Therapeutics Applied BioMath...
JCR Pharmaceuticals announces Completion of Acquisition of ArmaGen, Inc.
Tuesday, April 28, 2020JCR Pharmaceuticals Co Ltd announced that it has completed the previously announced acquisition of ArmaGen Inc a privately held US biopharmaceutical company headquartered in San Diego California ArmaGen
Tiziana Life Sciences Acquires a Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D
Monday, April 27, 2020Tiziana Life Sciences plc a biotechnology company focused on innovative therapeutics for inflammatory autoimmune and infectious diseases announced today that it pursuant to an asset purchase agreement it has acquired all of the intellectual property...
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
Monday, April 27, 2020Sutro Biopharma Inc a clinicalstage drug discovery development and manufacturing company focused on the application of precise protein engineering and rational design to create nextgeneration oncology therapeutics today announced updated interim data...
ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)
Friday, April 24, 2020ProThera Biologics Inc and Takeda Pharmaceutical Company Limited announced that they have entered into a global licensing agreement to develop a novel plasmaderived Interalpha Inhibitor Proteins IAIP therapy for the treatment of acute inflammatory co...
Hansoh Pharma and NiKang Therapeutics Enter into a Development and Commercialization Partnership for a Novel Treatment for Anti-Viral Diseases in China
Friday, April 24, 2020Hansoh Pharmaceutical Group Company Limited Hansoh Pharma a leading biopharmaceutical company in China and NiKang Therapeutics Inc NiKang a USbased early stage biotech company focused on discovering and developing innovative small molecule medicines...
Targovax and Valo Therapeutics Enter Collaboration to Develop RAS Neoantigen Coating of ONCOS Viruses Using PeptiCRAd Technology
Thursday, April 23, 2020Targovax ASA a clinical stage immunooncology company developing oncolytic viruses and cancer vaccines to target hardtotreat solid tumors and Valo Therapeutics Valo Tx announce that they have entered into a collaboration agreement to evaluate PeptiCR...
Cara Care Announces Collaboration With Consumer Healthcare Business Unit of Sanofi Germany for Digestive Health
Thursday, April 23, 2020Digital health company HiDoc Technologies GmbH dba Cara Care has teamed up with the Consumer Healthcare Business Unit of Sanofi Germany on a holistic approach to digestive health that bundles Sanofis Buscomint bei Reizdarm pharmaceutical drug with Ca...
Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies Focused on Natural Killer (NK) Cells
Wednesday, April 22, 2020Gilead Sciences Inc Kite a Gilead Company and oNKoinnate announced the companies have entered into a threeyear cancer immunotherapy research collaboration to support discovery and development of nextgeneration drug and engineered cell therapies focus...
Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells
Wednesday, April 22, 2020Mogrify Ltd Mogrify a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions and Sangamo Therapeutics Sangamo Nasdaq SGMO a genomic medicine company today announced that they have execut...
